DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 142 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2017. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,533,000 | -3.2% | 362,826 | +26.0% | 0.02% | -5.9% |
| Q1 2018 | $5,715,000 | -40.9% | 287,918 | -44.3% | 0.02% | -39.3% |
| Q4 2017 | $9,670,000 | -40.1% | 517,150 | -31.2% | 0.03% | -40.4% |
| Q3 2017 | $16,151,000 | +107.7% | 751,201 | -6.8% | 0.05% | +104.3% |
| Q2 2017 | $7,777,000 | +95.2% | 805,920 | +194.8% | 0.02% | +91.7% |
| Q2 2016 | $3,985,000 | +5.4% | 273,362 | +39.0% | 0.01% | 0.0% |
| Q1 2016 | $3,782,000 | -33.5% | 196,615 | -16.4% | 0.01% | -29.4% |
| Q4 2015 | $5,685,000 | +3.1% | 235,268 | +4.7% | 0.02% | 0.0% |
| Q3 2015 | $5,515,000 | – | 224,763 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |